{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "18447141",
  "DateCompleted": {
    "Year": "2008",
    "Month": "09",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1018-9068",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "2",
        "PubDate": {
          "Year": "2008"
        }
      },
      "Title": "Journal of investigational allergology & clinical immunology",
      "ISOAbbreviation": "J Investig Allergol Clin Immunol"
    },
    "ArticleTitle": "Acute generalized exanthematous pustulosis due to tetrazepam.",
    "Pagination": {
      "StartPage": "119",
      "EndPage": "122",
      "MedlinePgn": "119-22"
    },
    "Abstract": {
      "AbstractText": [
        "Tetrazepam is a benzodiazepine that is widely used in Spain as a muscle relaxant, with occasional cutaneous side effects. We report a patient who developed a generalized pruriginous cutaneous reaction compatible with acute generalized exanthematous pustulosis (AGEP) due to tetrazepam. Patch tests with bromazepam, diazepam, and tetrazepam were negative at 48 and 72 hours; however, the tetrazepam patch showed a positive reaction at 10 days. Immunohistochemical studies revealed a mononuclear infiltrate composed of CD4+ and CD8+ T lymphocytes. Analysis of interleukin (IL) 8 expression by quantitative polymerase chain reaction revealed increased IL-8 mRNA levels in patch test-positive skin. Lymphoblast transformation test (LTT) was positive with tetrazepam but not with diazepam. Positive patch test and LTT suggested that tetrazepam-specific lymphocytes might be responsible for a T cell-mediated reaction. These results support previous data suggesting an important role for IL-8 and drug-specific T cells in the pathogenesis ofAGEP and imply that the reaction was specific to tetrazepam with no cross-reactivity to other benzodiazepines."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Allergy Department, Hospital La Paz, Madrid, Spain."
          }
        ],
        "LastName": "Thomas",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bell\u00f3n",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Barranco",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Padial",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tapia",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Morel",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alves-Ferreira",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mart\u00edn-Esteban",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "J Investig Allergol Clin Immunol",
    "NlmUniqueID": "9107858",
    "ISSNLinking": "1018-9068"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Muscle Relaxants, Central"
    },
    {
      "RegistryNumber": "12794-10-4",
      "NameOfSubstance": "Benzodiazepines"
    },
    {
      "RegistryNumber": "FO92091VP8",
      "NameOfSubstance": "tetrazepam"
    },
    {
      "RegistryNumber": "UX6OWY2V7J",
      "NameOfSubstance": "Codeine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Arthralgia"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Benzodiazepines"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Codeine"
    },
    {
      "QualifierName": [
        "drug therapy",
        "immunology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Eruptions"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Drug Hypersensitivity"
    },
    {
      "QualifierName": [
        "chemically induced",
        "immunology"
      ],
      "DescriptorName": "Erythema"
    },
    {
      "QualifierName": [
        "chemically induced",
        "immunology"
      ],
      "DescriptorName": "Exanthema"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Muscle Relaxants, Central"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Skin Tests"
    }
  ]
}